- Walgreens expanding scope of retail pharmacy experience and services heading into fiscal 2014
- Shot@Life program ambassador Amanda Peet gets flu shot in NYC Walgreens to support 'Get a Shot, Give a Shot'
- Walgreens firing on all cylinders as chain realizes a total comp sales increase of 5.4% for its first quarter
- Bloomberg: Greg Wasson joins thought leaders to discuss the state of health care in the United States
- Report: Specialty pharmacy to account for half of all prescription revenue by 2018
OKLAHOMA CITY — Following the sale of ApothecaryRx pharmacies to Walgreens, Graymark Healthcare said it is shifting its focus to sleep disorders, including obstructive sleep apnea.
Graymark is one of the largest providers of sleep medicine diagnosis and treatment, owning and operating diagnostic sleep centers that treat a wide range of sleep disorders, and also operates a medical equipment supply company that provides disposable and durable medical equipment.
"Millions of Americans suffer from obstructive sleep apnea, and many aren't aware they have a problem or that treatment is available in their communities," said Stanton Nelson, chairman and CEO of Graymark Healthcare. "As a pure-play sleep disorders company focused primarily on obstructive sleep apnea, we believe Graymark is better able to help people sleep better."
Graymark announced its sale of ApothecaryRx pharmacies, which operates 18 pharmacies across five states, to Walgreens in late August.